View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Pierre FerraguÊ
  • Pierre FerraguÊ

Waymo & Toyota partner in driverless & consumer AVs. Our take

Waymo and Toyota announced a strategic partnership this week. Click on the link below for key facts, and our take.

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
WELL WELLTOWER INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
VTR VENTAS INC.
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ITOS KEROS THERAPEUTICS
ZNTL ITEOS THERAPEUTICS
LRMR ZENTALIS PHARMACEUTICALS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
MRVL ELEVATION ONCOLOGY
STX MARVELL TECHNOLOGY INC
APP SEAGATE TECHNOLOGY HLDGS PLC
ATXS APPLOVIN CORP
GFS ASTRIA THERAPEUTICS INC
GMTX GLOBALFOUNDRIES INC
VIGL GEMINI THERAPEUTICS INC
TYRA VIGIL NEUROSCIENCE INC
EWTX TYRA BIOSCIENCES INC
DDI EDGEWISE THERAPEUTICS INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
SKLZ APOGEE THERAPEUTICS INC
EMBRAC B SKILLZ INC
MXL-US EMBRACER GROUP AB
MAXLINEAR
INC.
Daniel Ives ... (+3)
  • Daniel Ives
  • Sam Brandeis
  • Steven Wahrhaftig

Tesla Inc: 1 director

A director at Tesla Inc bought 4,000 shares at 256.308USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

Jonathan Chaplin
  • Jonathan Chaplin

CHTR and CMCSA: correcting price comparisons

This note corrects the pricing comparison we showed for Comcast and Charter last week. When we checked pricing on the Charter website, we were presented with an old Spectrum One offer, for some reason. In this note, we include a more complete comparison of pricing across both categories of offers available at both companies. The punchline: Charter’s rack rates have come down a lot.

XLSmart Telecom Sejahtera Tbk Pt: 2 directors

Two Directors at XLSmart Telecom Sejahtera Tbk Pt sold 6,722,914 shares at 2,350.000IDR. The significance rating of the trade was 95/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...

Adrian Loh Tzum Yung ... (+14)
  • Adrian Loh Tzum Yung
  • Bella Lu Yifei
  • Benjaphol Suthwanish
  • Carol Dou Xiao Qin
  • Jack Goh Tooan Orng
  • Jonathan Koh
  • Julia Pan Mengyao
  • Kampon Akaravarinchai
  • Ken Lee
  • Ming San Soong
  • Paula Ruth
  • Posmarito Pakpahan
  • Sunny Chen
  • Thanawat Thangchadakorn

Regional Morning Meeting Notes: Friday, April 25, 2025

GREATER CHINA Results Aier Eye Hospital Group (300015 CH/BUY/Rmb12.72/Target: Rmb17.80) 2024: Satisfactory results; expects strong recovery in 2025. Upgrade to BUY. Ningbo Tuopu Group Co (601689 CH/BUY/Rmb50.96/Target: Rmb83.00) 4Q24: Earnings up 38.5% yoy, in line. Maintain BUY with target price unchanged at Rmb83.00. TAL Educational Group (TAL US/BUY/US$9.36/Target: US$14.00) 4QFY25: Earnings miss amid ramped-up investments in AI-powered learning. INDONESIA Sector Telecommun...

Jonathan Chaplin
  • Jonathan Chaplin

T-Mobile: Quick thoughts following the 1Q25 call

What’s new: in this note we cover the case for T-Mobile buying a cable asset and what we learned about the odds of this from the call, new insights into T-Mobile’s fiber strategy, what it means for Cable and Fiber assets, further thoughts on the slowdown in growth in the broadband market, important insights into what might be driving the strength in the mobile market, and how T-Mobile will approach tariffs. We will publish a separate comprehensive review of results and model update shortly.

Jonathan Chaplin
  • Jonathan Chaplin

Comcast Post-1Q25 Model Update

What’s new: In this note, we cover changes to our estimates, and comparisons with guidance and consensus. Please see separate notes reviewing results and thoughts following the earnings call. The most significant changes are higher broadband losses and lower EBITDA in 2025. We expect Consensus to increase broadband losses as well as lower EBITDA. No change to thesis. Price target is $38 (+15%).

Jonathan Chaplin
  • Jonathan Chaplin

CMCSA: Quick thoughts following the call 1Q25

What’s new: in this note we cover the source of the pressure Comcast is seeing on broadband growth (market vs competition), we cover the potential causes of slower market growth, we cover the causes of competitive pressures and the impact of recent pricing changes, and we touch on implications for ARPU and EBITDA growth.

 PRESS RELEASE

[Communiqué de presse] Mise à disposition du document d’enregistrement...

[Communiqué de presse] Mise à disposition du document d’enregistrement universel d’iliad S.A. Communiqué de presse                                                                                        Paris, le 24 avril 2025 Mise à disposition du document d’enregistrement universel d’iliad S.A. information réglementée Le document d’enregistrement universel d’iliad S.A. a été déposé le 24 avril 2025 auprès de la Commission de Surveillance du Secteur Financier (« CSSF »), en sa qualité d’autorité compétente au titre du règlement (UE) 2017/1129, sans approbation préalable conformément à...

Jonathan Chaplin
  • Jonathan Chaplin

CMCSA 1Q25 Quick Take

What’s new: Revenue in-line. EBITDA beat expectations handily, due mostly to better results in C&E. C&P revenue and EBITDA was in-line, with weak subscriber trends and slightly better than expected ARPU.

Blair Levin
  • Blair Levin

In Good News for CMSCA, DIS (and Robocallers and Pirate Radio, Among O...

What’s New: The Fifth Circuit overturned the FCC’s 2020 and 2024 decisions to impose a $57 million fine against T for actions related to improper use customer data. Based on a recent Supreme Court decision, the appellate court ruled that the FCC actions violate T’s Seventh Amendment right to a jury trial, likely upending broader FCC enforcement efforts. In this note we analyze the impact of the Court’s decision on our coverage universe generally and well as specifically to some of the companie...

Pierre FerraguÊ
  • Pierre FerraguÊ

Tesla 1Q25: Catalysts on track. Buy, $465

We see good reasons to buy the bottom on Tesla. For details see the attached article.

Jonathan Chaplin
  • Jonathan Chaplin

CMCSA: Free Wireless Line for All Broadband Customers

What’s new: Wepublished a brief note yesterday on the rising competitive intensity in Wireless following T-Mobile’s launch of new plans. Later in the day, Comcast launched a new Wireless plan and new free-line promotions too. We cover Comcast’s new offers and the implications for the Company and the group in this brief note.

Daniel Ives ... (+2)
  • Daniel Ives
  • Sam Brandeis
Jonathan Chaplin
  • Jonathan Chaplin

T-Mobile's most recent price moves suggest rising competition

What’s new: Verizon reported mid-single-digit growth in gross adds after amending their offers in mid-March and double-digit growth in gross adds after launching a three-year price guarantee in April. T-Mobile responded with new plans that include a five-year price guarantee this morning. We cover implications for the industry in this quick comment.

Blair Levin
  • Blair Levin

Another Starlink v. DISH Spectrum Battle

What’s New: Another front has opened in the long running war between SpaceX/Starlink and DISH/EchoStar. In this latest one, SpaceX argues that DISH’s utilization of its AWS-4 band should compel the FCC to start a rulemaking to establish a new framework for sharing the 2 GHz MSS band. In this note, we summarize SpaceX’s arguments, DISH’s response, what FCC precedent and the relevant Trump agenda tells us, as well as the great unknown about the level of Musk’s influence at the FCC.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch